HUP0300595A3 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: HUP0300595A3
Authority: HU; Hungary
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2000-04-27

Application number

HU0300595A

Other languages

English (en)

Hungarian (hu)

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2001-04-26

Publication date

2007-06-28

2001-04-26 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2003-06-28 Publication of HUP0300595A2 publication Critical patent/HUP0300595A2/hu

2007-06-28 Publication of HUP0300595A3 publication Critical patent/HUP0300595A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Wood Science & Technology (AREA)
Neurosurgery (AREA)
Biotechnology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Microbiology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
General Engineering & Computer Science (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Oncology (AREA)
Diabetes (AREA)

HU0300595A 2000-04-27 2001-04-26 Novel compounds HUP0300595A3 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US19996300P	2000-04-27	2000-04-27
US20333600P	2000-05-11	2000-05-11
US20708700P	2000-05-25	2000-05-25
US20754600P	2000-05-26	2000-05-26
PCT/US2001/013360 WO2001081363A1 (fr)	2000-04-27	2001-04-26	Nouveaux composes

Publications (2)

Publication Number	Publication Date
HUP0300595A2 HUP0300595A2 (hu)	2003-06-28
HUP0300595A3 true HUP0300595A3 (en)	2007-06-28

Family

ID=27498358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0300595A HUP0300595A3 (en)	2000-04-27	2001-04-26	Novel compounds

Country Status (15)

Country	Link
EP (1)	EP1276755A4 (fr)
JP (1)	JP2003530869A (fr)
KR (1)	KR20030032940A (fr)
CN (1)	CN1439017A (fr)
AU (1)	AU2001257265A1 (fr)
BR (1)	BR0110402A (fr)
CA (1)	CA2407449A1 (fr)
CZ (1)	CZ20023548A3 (fr)
HK (1)	HK1053840A1 (fr)
HU (1)	HUP0300595A3 (fr)
IL (1)	IL152416A0 (fr)
MX (1)	MXPA02010692A (fr)
NO (1)	NO20025151L (fr)
PL (1)	PL358580A1 (fr)
WO (1)	WO2001081363A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7034132B2 (en)	2001-06-04	2006-04-25	Anderson David W	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6558936B1 (en) *	1999-10-01	2003-05-06	Millennium Pharmaceuticals, Inc.	Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en)	2000-02-11	2003-10-07	Millennium Pharmaceuticals, Inc.	14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) *	2000-06-22	2004-06-25	Smithkline Beecham Corp	Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
JP2004516813A (ja) *	2000-06-30	2004-06-10	インサイト・ゲノミックス・インコーポレイテッド	関連腫瘍マーカー
US6924364B2 (en)	2000-08-04	2005-08-02	Zymogenetics, Inc.	Human secreted protein, Zzp1
US7358353B2 (en)	2000-08-22	2008-04-15	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US6863892B2 (en)	2000-08-22	2005-03-08	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002026826A2 (fr) *	2000-09-27	2002-04-04	Curagen Corporation	Nouvelles proteines et acides nucleiques codant pour celles-ci
AU1181802A (en)	2000-09-27	2002-04-08	Curagen Corp	Novel proteins and nucleic acids encoding same
US20020151695A1 (en) *	2000-11-28	2002-10-17	Shuqian Jing	Transforming growth factor-beta-related molecules and uses thereof
US6958387B2 (en)	2001-03-08	2005-10-25	Immunex Corporation	Human serpin polypeptides
US6921807B2 (en)	2001-03-29	2005-07-26	Zymogenetics, Inc.	Proteinase inhibitor ZSERP9
US7033790B2 (en)	2001-04-03	2006-04-25	Curagen Corporation	Proteins and nucleic acids encoding same
US20020172995A1 (en) *	2001-05-17	2002-11-21	Wei Shao	Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20040259779A1 (en) *	2001-07-06	2004-12-23	Teit Johansen	Novel neurotrophic factors
US20030215852A1 (en) *	2002-04-01	2003-11-20	Wyeth	Novel pancortin-Pablo protein interactions and methods of use thereof
WO2004069869A1 (fr) *	2003-02-10	2004-08-19	Taisho Pharmaceutical Co., Ltd.	Gene provoquant l'apoptose et son utilisation
AU2004210975B2 (en) *	2003-02-10	2008-04-10	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US20050048615A1 (en) *	2003-08-01	2005-03-03	Fox Brian A.	Adipocyte complement related protein zacrp11
US7399469B2 (en)	2004-03-26	2008-07-15	Pdl Biopharma, Inc.	Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
US8968742B2 (en)	2012-08-23	2015-03-03	Agensys, Inc.	Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
CN108697907A (zh) *	2016-01-06	2018-10-23	耶达研究及发展有限公司	用于治疗恶性疾病、自身免疫疾病和炎性疾病的组合物和方法
CN108178797B (zh) *	2017-12-29	2020-12-01	西南大学	一种抗家蚕BmSRC多克隆抗血清、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5830744A (en) *	1995-06-06	1998-11-03	Human Genome Sciences, Inc.	Gene encoding human Dnase
JPH09512715A (ja) *	1994-05-05	1997-12-22	ヒューマンジノームサイエンシーズ，インコーポレイテッド	ヒトｄｎａｓｅ
AU3395900A (en) *	1999-03-12	2000-10-04	Human Genome Sciences, Inc.	Human lung cancer associated gene sequences and polypeptides

2001
- 2001-04-26 EP EP01930760A patent/EP1276755A4/fr not_active Withdrawn
- 2001-04-26 CZ CZ20023548A patent/CZ20023548A3/cs unknown
- 2001-04-26 BR BR0110402-0A patent/BR0110402A/pt not_active IP Right Cessation
- 2001-04-26 PL PL01358580A patent/PL358580A1/xx unknown
- 2001-04-26 KR KR1020027014463A patent/KR20030032940A/ko not_active Withdrawn
- 2001-04-26 HK HK03104434.3A patent/HK1053840A1/zh unknown
- 2001-04-26 WO PCT/US2001/013360 patent/WO2001081363A1/fr not_active Ceased
- 2001-04-26 AU AU2001257265A patent/AU2001257265A1/en not_active Abandoned
- 2001-04-26 MX MXPA02010692A patent/MXPA02010692A/es unknown
- 2001-04-26 JP JP2001578451A patent/JP2003530869A/ja not_active Withdrawn
- 2001-04-26 HU HU0300595A patent/HUP0300595A3/hu unknown
- 2001-04-26 CA CA002407449A patent/CA2407449A1/fr not_active Abandoned
- 2001-04-26 CN CN01811752A patent/CN1439017A/zh active Pending
- 2001-04-26 IL IL15241601A patent/IL152416A0/xx unknown
2002
- 2002-10-25 NO NO20025151A patent/NO20025151L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2001081363A1 (fr)	2001-11-01
CA2407449A1 (fr)	2001-11-01
NO20025151D0 (no)	2002-10-25
AU2001257265A1 (en)	2001-11-07
EP1276755A4 (fr)	2004-03-31
HUP0300595A2 (hu)	2003-06-28
NO20025151L (no)	2002-12-13
CN1439017A (zh)	2003-08-27
MXPA02010692A (es)	2003-03-10
EP1276755A1 (fr)	2003-01-22
BR0110402A (pt)	2003-02-11
CZ20023548A3 (cs)	2003-05-14
JP2003530869A (ja)	2003-10-21
KR20030032940A (ko)	2003-04-26
HK1053840A1 (zh)	2003-11-07
PL358580A1 (en)	2004-08-09
IL152416A0 (en)	2003-05-29

Publication	Publication Date	Title
AU7476301A (en)	2002-01-02	Novel compounds
HUP0300595A3 (en)	2007-06-28	Novel compounds
AU9261901A (en)	2002-03-26	Novel compounds
GB0003019D0 (en)	2000-03-29	Novel compounds
EP1255771A4 (fr)	2004-09-29	Nouveaux composes
GB0008464D0 (en)	2000-05-24	Novel compounds
EP1292617A4 (fr)	2005-04-06	Composes
EP1472352A4 (fr)	2005-10-12	Nouveaux composes
EP1343813A4 (fr)	2004-11-17	Nouveaux composes
AU7476401A (en)	2002-01-02	Novel compounds
EP1276866A4 (fr)	2005-03-16	Nouveaux composes
EP1299530A4 (fr)	2005-03-09	Nouveaux composes
GB0001898D0 (en)	2000-03-22	Novel compounds
GB0003636D0 (en)	2000-04-05	Novel compounds
GB0002402D0 (en)	2000-03-22	Novel compounds
GB0004196D0 (en)	2000-04-12	Novel compounds
EG22332A (en)	2002-12-31	Novel compounds
GB0002195D0 (en)	2000-03-22	Novel compounds
GB0006577D0 (en)	2000-05-10	Novel compounds
GB0002191D0 (en)	2000-03-22	Novel compounds
GB0002330D0 (en)	2000-03-22	Novel compounds
GB0005256D0 (en)	2000-04-26	Novel compounds
GB0026911D0 (en)	2000-12-20	Novel compounds
GB0006168D0 (en)	2000-05-03	Novel compounds
GB0008807D0 (en)	2000-05-31	Novel compounds

Legal Events

Date	Code	Title	Description
2008-05-28	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished